FDAnews
www.fdanews.com/articles/147468-antares-pharma-announces-positive-results-from-vibex-mtx-usability-study

Antares Pharma Announces Positive Results from VIBEX MTX Usability Study

June 26, 2012
Antares Pharma announced positive results from a human factors usability study for VIBEX Methotrexate, a proprietary auto injector product designed to self-administer a rapid subcutaneous weekly injection of methotrexate for the treatment of rheumatoid arthritis.
MarketWatch